Status:
RECRUITING
Weight Management in Overweight Endometrial Cancer Patients Undergoing Fertility-sparing Treatment
Lead Sponsor:
Peking University People's Hospital
Conditions:
Endometrium Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
In this study, overweight and obese patients with endometrial cancer treated with fertility- sparing therapy were randomly divided into two groups. The test group was given weight management, while th...
Detailed Description
Obesity is recognized as a major risk factor for the development of endometrial cancer. Notably, several retrospective studies have shown that obesity reduces complete remission and pregnancy rates an...
Eligibility Criteria
Inclusion
- age ≥18 years old
- diagnosed as endometrial cancer or atypical hyperplasia
- immunohistochemical staining and sequencing of pathological tissue
- fertility-preserving therapy
- BMI≥25 kg/m2
- informed consent.
Exclusion
- those with communication barriers
- pregnant women
- medical and surgical serious complications: urinary calculi, history of renal failure or severe renal insufficiency, familial dyslipidemia, severe liver disease, chronic metabolic acidosis, history of pancreatitis, severe diabetes mellitus, active gallbladder disease, fat dyspepsia, severe cardiovascular and cerebrovascular diseases.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT06169449
Start Date
April 1 2022
End Date
December 31 2026
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University People's Hospital
Beijing, China, China, 100044